09:58 AM EST - MediPharm Labs Corp. : Today announced its financial results for the full year ended December 31, 2024. Net revenue increased by $9M or 27% to $42M versus prior year of $33M. Gross profit of $12.8M or 31% representing a significant improvement over 2023 of $5.8M or 18%. Adjusted EBITDA loss of $1.9M which improved $8.3M or 81% versus 2023. Adjusted EBITDA continues to improve driven by margin expansion initiatives and cost reductions MediPharm Labs Corp.
shares T.LABS are trading down $0.01 at $0.10.
